“This is the second nitinol staple-related patent that GEO has added to its arsenal. This inserter has been commercially available since 2019 and feedback from the surgeon community is tremendous. The efficacy and ease of use makes this one of the more popular solutions that GEO has in the market,” said Michael Simpson, GEO’s Chief Executive Officer. “Having this system RFID-tracked inside the GEO CART along with a complete disposable instrument set adds additional opportunity to increase patient safety and lower healthcare costs.”
“This is the second nitinol staple-related patent that GEO has added to its arsenal. This inserter has been commercially available since 2019 and feedback from the surgeon community is tremendous. The efficacy and ease of use makes this one of the more popular solutions that GEO has in the market,” said Michael Simpson, GEO’s Chief Executive Officer. “Having this system RFID-tracked inside the GEO CART along with a complete disposable instrument set adds additional opportunity to increase patient safety and lower healthcare costs.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
